Format

Send to

Choose Destination
J Pharm Sci. 2014 May;103(5):1315-30. doi: 10.1002/jps.23931. Epub 2014 Mar 12.

Impact of residual impurities and contaminants on protein stability.

Author information

1
Pfizer Inc, Chesterfield, Missouri, 63017.

Abstract

Production of recombinant proteins generates a variety of process-related impurities. The multistep manufacturing processes may introduce many potential contaminants into the final pharmaceutical products. These residual impurities and contaminants can potentially impact the protein stability significantly. In this short review, the authors intend to discuss major sources and types of residual process-related impurities and potential product contaminants, their impact on protein quality/stability, and possible mitigations during product development and manufacturing processes.

KEYWORDS:

biotechnology; deamidation; formulation; oxidation; protein aggregation

PMID:
24623189
DOI:
10.1002/jps.23931
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center